{
  "id": "mhgap#referral_51b84e6e",
  "title_en": "General — Referral",
  "title_vi": "General — Chuyển tuyến",
  "text_en": "References 1. Global burden of disease 2019: mental disorders 8. Dua T, Barbui C, Patel AA, Tablante EC, Thornicroft – level 2 cause [website]. Seattle: Institute for G, Saxena S; WHO's mhGAP guideline team. Health Metrics and Evaluations; 2021 (http://www. Discussion of the updated WHO recommendations healthdata.org/results/gbd_summaries/2019/ for mental, neurological, and substance use mental-disorders-level-2-cause, accessed 25 disorders. Lancet Psychiatry. 2016;3(11):1008–12 October 2023). (https://doi.org/10.1016/s2215-0366(16)30184-5). 2. Dua T, Barbui C, Clark N, Fleischmann A, Poznyak V, 9. mhGAP intervention guide for mental, van Ommeren M et al. Evidence-based guidelines neurological and substance use disorders in non- for mental, neurological, and substance use specialized health settings: mental health Gap disorders in low- and middle-income countries: Action Programme (mhGAP), version 2.0. Geneva: summary of WHO recommendations. PLoS Med. World Health Organization; 2016 (https://iris.who. 2011;8(11): e1001122 (https://doi.org/10.1371/ int/handle/10665/250239). journal.pmed.1001122). 10. WHO handbook for guideline development, 2nd 3. Intersectoral global action plan on epilepsy and edition. Geneva: World Health Organization; 2014 other neurological disorders 2022–2031. Geneva: (https://iris.who.int/handle/10665/145714). World Health Organization; 2023 (https://iris.who. 11. Keynejad RC, Dua T, Barbui C, Thornicroft G. WHO int/handle/10665/371495). Mental Health Gap Action Programme (mhGAP) 4. Thornicroft G, Sunkel C, Alikhon Aliev A, Baker Intervention guide: a systematic review of S, Brohan E, el Chammay R et al. The Lancet evidence from low and middle-income countries. Commission on ending stigma and discrimination Evid Based Ment Health. 2018;21(1):29–33 (http:// in mental health. Lancet. 2022;400:1438–80 dx.doi.org/10.1136/eb-2017-102750). (https://doi.org/10.1016/S0140-6736(22)01470-2). 12. Keynejad R, Spagnolo J, Thornicroft G. WHO 5. mhGAP: Mental Health Gap Action Programme: mental health gap action programme (mhGAP) scaling up care for mental, neurological and intervention guide: updated systematic review substance use disorders. Geneva: World Health on evidence and impact. Evid Based Ment Health. Organization; 2008 (https://apps.who.int/iris/ 2021;24(3):124–30 (http://dx.doi.org/10.1136/ handle/10665/43809). ebmental-2021-300254). 6. mhGAP intervention guide for mental, 13. The selection and use of essential medicines 2023: neurological and substance use disorders in web annex A: World Health Organization model non-specialized health settings: mental health list of essential medicines: 23rd list. Geneva: World Gap Action Programme (mhGAP). Geneva: World Health Organization; 2023 (https://iris.who.int/ Health Organization; 2010 (https://apps.who.int/ handle/10665/371090). iris/handle/10665/44406). 14. Comprehensive mental health action plan 2013– 7. Update of the Mental Health Gap Action 2030. Geneva: World Health Organization; 2021 Programme (mhGAP) guidelines for mental, (https://iris.who.int/handle/10665/345301). neurological and substance use disorders, 2015. 15. Global action plan on the public health response Geneva: World Health Organization; 2015 to dementia 2017–2025. Geneva: World Health (https://apps.who.int/iris/handle/10665/204132). Organization; 2017 (https://iris.who.int/ handle/10665/259615). 115 Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological",
  "gloss_vi": "References 1. global burden of disease 2019: mental disorders 8.",
  "source": "WHO mhGAP-IG 2023",
  "url": "https://www.who.int/",
  "lang": "en",
  "axes": {
    "type": [
      "clinical"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "referral"
    ],
    "life_topics": [],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Referral General — Chuyển tuyến References 1. Global burden of disease 2019: mental disorders 8. Dua T, Barbui C, Patel AA, Tablante EC, Thornicroft – level 2 cause [website]. Seattle: Institute for G, Saxena S; WHO's mhGAP guideline team. Health Metrics and Evaluations; 2021 (http://www. Discussion of the updated WHO recommendations healthdata.org/results/gbd_summaries/2019/ for mental, neurological, and substance use mental-disorders-level-2-cause, accessed 25 disorders. Lancet Psychiatry. 2016;3(11):1008–12 October 2023). (https://doi.org/10.1016/s2215-0366(16)30184-5). 2. Dua T, Barbui C, Clark N, Fleischmann A, Poznyak V, 9. mhGAP intervention guide for mental, van Ommeren M et al. Evidence-based guidelines neurological and substance use disorders in non- for mental, neurological, and substance use specialized health settings: mental health Gap disorders in low- and middle-income countries: Action Programme (mhGAP), version 2.0. Geneva: summary of WHO recommendations. PLoS Med. World Health Organization; 2016 (https://iris.who. 2011;8(11): e1001122 (https://doi.org/10.1371/ int/handle/10665/250239). journal.pmed.1001122). 10. WHO handbook for guideline development, 2nd 3. Intersectoral global action plan on epilepsy and edition. Geneva: World Health Organization; 2014 other neurological disorders 2022–2031. Geneva: (https://iris.who.int/handle/10665/145714). World Health Organization; 2023 (https://iris.who. 11. Keynejad RC, Dua T, Barbui C, Thornicroft G. WHO int/handle/10665/371495). Mental Health Gap Action Programme (mhGAP) 4. Thornicroft G, Sunkel C, Alikhon Aliev A, Baker Intervention guide: a systematic review of S, Brohan E, el Chammay R et al. The Lancet evidence from low and middle-income countries. Commission on ending stigma and discrimination Evid Based Ment Health. 2018;21(1):29–33 (http:// in mental health. Lancet. 2022;400:1438–80 dx.doi.org/10.1136/eb-2017-102750). (https://doi.org/10.1016/S0140-6736(22)01470-2). 12. Keynejad R, Spagnolo J, Thornicroft G. WHO 5. mhGAP: Mental Health Gap Action Programme: mental health gap action programme (mhGAP) scaling up care for mental, neurological and intervention guide: updated systematic review substance use disorders. Geneva: World Health on evidence and impact. Evid Based Ment Health. Organization; 2008 (https://apps.who.int/iris/ 2021;24(3):124–30 (http://dx.doi.org/10.1136/ handle/10665/43809). ebmental-2021-300254). 6. mhGAP intervention guide for mental, 13. The selection and use of essential medicines 2023: neurological and substance use disorders in web annex A: World Health Organization model non-specialized health settings: mental health list of essential medicines: 23rd list. Geneva: World Gap Action Programme (mhGAP). Geneva: World Health Organization; 2023 (https://iris.who.int/ Health Organization; 2010 (https://apps.who.int/ handle/10665/371090). iris/handle/10665/44406). 14. Comprehensive mental health action plan 2013– 7. Update of the Mental Health Gap Action 2030. Geneva: World Health Organization; 2021 Programme (mhGAP) guidelines for mental, (https://iris.who.int/handle/10665/345301). neurological and substance use disorders, 2015. 15. Global action plan on the public health response Geneva: World Health Organization; 2015 to dementia 2017–2025. Geneva: World Health (https://apps.who.int/iris/handle/10665/204132). Organization; 2017 (https://iris.who.int/ handle/10665/259615). 115 Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological References 1. global burden of disease 2019: mental disorders 8."
}